U.S. RESEARCH ROUNDUP Argenx SE, Novo Nordisk, UMB Financial
Register now for FREE unlimited access to Reuters.com
Jan 4 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Argenx SE, Novo Nordisk and UMB Financial, on Tuesday.
HIGHLIGHTS
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
Register now for FREE unlimited access to Reuters.com
Compiled by Bengaluru Newsroom
Our Standards: The Thomson Reuters Trust Principles.